Expert Strategies to Optimize the Treatment of Patients With Squamous NSCLC

Register now for this complimentary, live 1-hour CME/CE/CPE-certified meeting where you can gain expert guidance on the optimal management of squamous NSCLC and interact with faculty. Afterward, an associated downloadable slideset, on-demand Webcast, and 2 FAQ modules will be available on the CCO Web site to enhance the information presented at live meetings.


Epidemiology and Diagnosis of Patients With Squamous NSCLC

Optimal Management of Patients With Squamous NSCLC

  • Individualizing choice of frontline therapy
  • Advances in the management of patients after disease progression
  • Management of treatment-related adverse events

Future Directions for the Treatment of Squamous NSCLC

Question and Answer Session


Date / Time
Event Details


Program Director
Edward S. Kim, MD, FACP

Chair, Solid Tumor Oncology and Investigational Therapeutics
Donald S. Kim Distinguished Chair for Cancer Research
Levine Cancer Institute
Atrium Health
Charlotte, North Carolina

Program Director
Mark A. Socinski, MD

Executive Medical Director
Member, Thoracic Oncology Program
Florida Hospital Cancer Institute
Orlando, Florida


Young Kwang Chae, MD, MPH, MBA

Co-Director, Developmental Therapeutics Program
Division of Hematology Oncology
Assistant Professor
Department of Medicine
Northwestern University Feinberg School of Medicine
Robert H. Lurie Comprehensive Cancer Center
Northwestern University
Chicago, Illinois

Sarah Goldberg, MD, MPH

Assistant Professor of Medicine (Medical Oncology)
Yale University School of Medicine
New Haven, Connecticut

Thomas A. Hensing, MD

Clinical Associate Professor of Medicine
Department of Hematology and Oncology
University of Chicago
Chicago, Illinois
Co-Director, Thoracic Oncology Program
Kellogg Cancer Center
NorthShore University HealthSystem
Evanston, Illinois

Leora Horn, MD, MSc, FRCPC

Ingram Associate Professor of Cancer Research 
, Thoracic Oncology Research Program 
Assistant Vice Chairman for Faculty Development 
Vanderbilt Ingram Cancer Center 
Nashville, Tennessee

Paul K. Paik, MD

Assistant Attending
Thoracic Oncology Service
Memorial Sloan Kettering Cancer Center
New York, New York

Nathan Pennell, MD, PhD

Associate Professor
Cleveland Clinic Lung Cancer Medical Oncology
Department of Hematology and Medical Oncology
Cleveland Clinic Taussig Cancer Institute
Cleveland, Ohio

Rathi Pillai, MD

Assistant Professor
Department of Hematology and Oncology
Winship Cancer Institute
Emory University
Atlanta, Georgia

Helen J. Ross, MD

Associate Professor
Head, Thoracic Malignancies
Consultant, Medical Oncology
Division of Hematology/Medical Oncology
Department of Medicine
Mayo Clinic
Scottsdale, Arizona

Thomas Stinchcombe, MD

Professor of Medicine
Department of Medicine
Duke University School of Medicine
Member, Duke Cancer Institute
Durham, North Carolina

Anne S. Tsao, MD

Division of Cancer Medicine
Department of Thoracic/Head and Neck Medical Oncology
Department of Mesothelioma Program
The University of Texas MD Anderson Cancer Center
Houston, Texas

The goal of this activity is to improve participants’ competence in providing optimal care for patients with squamous non-small-cell lung cancer.

Target Audience
This program is intended for physicians, registered nurses, pharmacists, and other healthcare professionals who care for patients with non-small-cell lung cancer.

Learning Objectives

  • Plan individualized treatment strategies for patients with newly diagnosed squamous NSCLC
  • Incorporate current evidence-based treatment recommendations into the care of patients with metastatic squamous NSCLC that has progressed on or after frontline therapy
  • Discuss promising investigational agents and emerging therapeutic strategies with patients with squamous NSCLC based on an understanding of available clinical data and ongoing clinical trials



Physician Continuing Medical Education

Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC. The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation
The Annenberg Center for Health Sciences at Eisenhower designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education

Accreditation Statement
Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Credit Designation
1.0 contact hour may be earned for successful completion of this activity.

California Board of Registered Nursing
Provider approved by the California Board of Registered Nursing, Provider Number 13664, for 1.0 contact hour.

A statement of credit will be issued only upon receipt of a completed activity evaluation form and will be emailed to you within 4 weeks

Pharmacist Continuing Education

ACPE logo

Accreditation Statement
The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Credit Designation
This program has been assigned ACPE Universal Activity #0797-9999-17-066-L01-P. This program is designated for up to 1.0 contact hour (0.10 CEUs) of continuing pharmacy education credit.

Type of Activity: Application

For Pharmacists: Upon receipt of the completed activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 4 weeks.

Disclosure of Conflicts of Interest 
The Annenberg Center for Health Sciences at Eisenhower requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to the Annenberg Center for Health Sciences at Eisenhower policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.